Find a Location

Stanford University

Palo Alto, CA, United States

Stanford University is one of twenty-two type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Darrell Wilson, MD, the TrialNet team at Stanford University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.   

The Hospital for Sick Children

Toronto, ON, Canada

The Hospital for Sick Children (SickKids) is one of twenty-two type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Diane Wherrett, MD, the TrialNet team at SickKids is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

University of California, San Francisco

San Francisco, CA, United States

University of California, San Francisco (UCSF) is one of twenty-two Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Stephen Gitelman, MD, the TrialNet team at UCSF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

University of Chicago

Chicago, IL, United States

Led by Principal Investigator, Lou Philipson, MD, the TrialNet team at the University of Chicago is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

University of Florida

Gainesville, FL, United States

The University of Florida (UF) is one of twenty-two Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Michael Haller, MD, the TrialNet team at UF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

University of Miami

Miami, FL, United States

Led by David Baidal, MD, the TrialNet team at University of Miami is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

University of Michigan

Ann Arbor, MI, United States

Led by Inas Thomas, MD, the TrialNet team at University of Michigan is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

University of Minnesota

Minneapolis, MN, United States

University of Minnesota is one of twenty-two type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Antoinette Moran, MD, the TrialNet team at University of Minnesota is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

University of Pittsburgh at UPMC Children's Hospital of Pittsburgh

Pittsburgh, PA, United States

University of Pittsburgh is one of twenty-two type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Ingrid Libman, MD, PhD, the TrialNet team at University of Pittsburgh is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. Our center is located at the Children's Hospital of Pittsburgh of UPMC.

University of South Florida

Tampa, FL, United States

Led by Henry Rodriguez, MD, the TrialNet team at University of South Florida (USF) is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.